Form 4: Exelixis Director Julie Smith Reports Stock Transactions
SEC Form 4
Director Julie Smith reports exercising stock options and selling shares of Exelixis, Inc. common stock.
Summary
- On February 27 and 28, 2025, Julie Smith, a director of Exelixis, Inc., engaged in multiple transactions involving the company's common stock.
- Smith exercised options to acquire 31,167 shares at $20.50 and 23,347 shares at $19.77 on February 27, and 19,294 shares at $19.77 on February 28.
- She also sold 54,514 shares on February 27 at a weighted average price of $38.13 and 19,294 shares on February 28 at $37.62.
- Following these transactions, Smith directly owns 10,778 shares of common stock and holds options to purchase 19,294 shares.
Sentiment
Score: 5
Explanation: Neutral sentiment as it's a standard disclosure of stock transactions by a company director.
Industry Context
Form 4 filings are standard disclosures for corporate insiders, providing transparency into their trading activities and potential alignment with shareholder interests.
Stakeholder Impact
- Shareholders may interpret insider transactions as a signal of management's confidence (or lack thereof) in the company's future prospects.
Key Dates
| Date | Description |
|---|---|
| 05/24/2018 | Option to purchase 31,167 shares became fully exercisable |
| 05/23/2019 | Option to purchase 42,641 shares became fully exercisable |
| 02/27/2025 | Earliest transaction date: Exercised options and sold shares |
| 02/28/2025 | Exercised options and sold shares |
| 05/23/2025 | Expiration date for option to purchase 31,167 shares |
| 05/22/2026 | Expiration date for option to purchase 42,641 shares |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.